Once touted as a COVID-19 'game changer,' Paxlovid is now a question mark for clinicians
Early trials showed Paxlovid could be a 'game changer' to keep people out of hospital. Yet the COVID-19 landscape has changed since then, with most people now protected against serious illness thanks to vaccination or past infections. So who should get the Pfizer antiviral going forward?
Source: cbc.ca